Trajectory of response to esketamine nasal spray for treatment resistant depression: findings from ESCAPE-TRD.
Eur Psychiatry June 16, 2026 Peer reviewed DOI: 10.1192/j.eurpsy.2026.12229 via PubMed
Abstract
Trajectory of response to esketamine nasal spray for treatment resistant depression: findings from ESCAPE-TRD.